Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

JP Nadda unveils Scheme for Medical Device Industry

JP Nadda unveils Scheme for Strengthening Medical Device Industry

Ruchika Sharma9 Nov 2024 12:12 PM IST

New Delhi: To provide a big boost to the medical devices industry, the Union Minister of Chemicals & Fertilizers and Health & Family Welfare,...

Lupin receives USFDA observations for two Pithampur manufacturing Units

Lupin bags tentative USFDA nod for Raltegravir Tablets for HIV-1 infection

Ruchika Sharma9 Nov 2024 11:00 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...

Max Healthcare profit up nearly 2 percent to Rs 282 crore in Q2

Ruchika Sharma8 Nov 2024 5:40 PM IST

New Delhi: Max Healthcare Institute has recorded a 1.9 per cent increase in consolidated net profit at Rs 281.81 crore for September quarter FY25, on...

Regular fire safety audit must in Pharma industry, says Telangana Fire Services DG

Ruchika Sharma8 Nov 2024 2:58 PM IST

Hyderabad: Telangana Fire Services Director General Y. Nagi Reddy emphasized the importance of conducting regular fire safety audits within the...

JnJ receives USFDA Approval for updated Varipulse Platform Irrigation Rate

Johnson & Johnson MedTech bags USFDA nod for the Varipulse Pulsed Field Ablation Platform for atrial fibrillation

Ruchika Sharma8 Nov 2024 11:00 AM IST

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform for the...

Granules India arm gets 1 USFDA observation for Hyderabad facility

Granules India Unit V facility receives USFDA EIR with 'No Action Indicated' status

Ruchika Sharma8 Nov 2024 10:00 AM IST

Hyderabad: Granules India Limited, a pharmaceutical manufacturing company, has announced that it has received an Establishment Inspection Report (EIR)...

Boehringer, Click Therapeutics investigational prescription digital therapeutic meets primary endpoint in study for schizophrenia

Boehringer Ingelheim, Broad Institute of MIT and Harvard to develop treatments for people with mental health conditions

Ruchika Sharma8 Nov 2024 9:00 AM IST

Ingelheim: Boehringer Ingelheim and researchers from the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard have agreed...

Sanofi Rilzabrutinib earns orphan designation in EU for IgG4 related disease

Sanofi, Regeneron Dupixent approved in EU for young children with eosinophilic esophagitis

Ruchika Sharma7 Nov 2024 3:55 PM IST

Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in...

KKR divests 5.8 percent stake in JB Chemicals & Pharma for Rs 1460 crore

KKR is said to consider selling USD 750 million stake in JB Pharma: Bloomberg

Ruchika Sharma7 Nov 2024 2:30 PM IST

KKR & Co., the U.S.-based private equity giant, is exploring a partial divestment of its controlling stake in JB Chemicals & Pharmaceuticals...

Apollo Ahmedabad Reinforces Commitment to Quality with Fourth JCI Accreditation

Apollo Hospitals exceeds Q2 profit forecast on strong demand for healthcare services

Ruchika Sharma7 Nov 2024 11:30 AM IST

Bengaluru: Apollo Hospitals Enterprise exceeded profit expectations for the second quarter, with increased demand for healthcare services driving...

Dr Reddy's Labs reports 9.5 percent fall in consolidated net profit after tax to Rs 1342 crore in Q2

Ruchika Sharma6 Nov 2024 4:29 PM IST

Indian generic drugmaker Dr Reddy's Laboratories recorded a 9.5 percent decline in its consolidated net profit after tax to Rs 13.42 billion (USD...

Delhi HC Cancels UNKIND Trademark, Upholds Mankind Pharmas KIND Family Rights

Mankind Pharma net profit increases 29 percent to Rs 659 crore in Q2

Ruchika Sharma6 Nov 2024 3:32 PM IST

New Delhi: Mankind Pharma has recorded a 29 per cent increase in consolidated net profit, reaching Rs 658.88 crore for the second quarter ended...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok